These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
691 related articles for article (PubMed ID: 16204034)
1. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse. Chen PC; Dudley S; Hagen W; Dizon D; Paxton L; Reichow D; Yoon SR; Yang K; Arnheim N; Liskay RM; Lipkin SM Cancer Res; 2005 Oct; 65(19):8662-70. PubMed ID: 16204034 [TBL] [Abstract][Full Text] [Related]
2. Novel roles for MLH3 deficiency and TLE6-like amplification in DNA mismatch repair-deficient gastrointestinal tumorigenesis and progression. Chen PC; Kuraguchi M; Velasquez J; Wang Y; Yang K; Edwards R; Gillen D; Edelmann W; Kucherlapati R; Lipkin SM PLoS Genet; 2008 Jun; 4(6):e1000092. PubMed ID: 18551179 [TBL] [Abstract][Full Text] [Related]
3. Meiotic arrest and aneuploidy in MLH3-deficient mice. Lipkin SM; Moens PB; Wang V; Lenzi M; Shanmugarajah D; Gilgeous A; Thomas J; Cheng J; Touchman JW; Green ED; Schwartzberg P; Collins FS; Cohen PE Nat Genet; 2002 Aug; 31(4):385-90. PubMed ID: 12091911 [TBL] [Abstract][Full Text] [Related]
4. Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers. Lipkin SM; Wang V; Stoler DL; Anderson GR; Kirsch I; Hadley D; Lynch HT; Collins FS Hum Mutat; 2001 May; 17(5):389-96. PubMed ID: 11317354 [TBL] [Abstract][Full Text] [Related]
5. Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Prolla TA; Baker SM; Harris AC; Tsao JL; Yao X; Bronner CE; Zheng B; Gordon M; Reneker J; Arnheim N; Shibata D; Bradley A; Liskay RM Nat Genet; 1998 Mar; 18(3):276-9. PubMed ID: 9500552 [TBL] [Abstract][Full Text] [Related]
6. Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6. Hegan DC; Narayanan L; Jirik FR; Edelmann W; Liskay RM; Glazer PM Carcinogenesis; 2006 Dec; 27(12):2402-8. PubMed ID: 16728433 [TBL] [Abstract][Full Text] [Related]
7. MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability. Lipkin SM; Wang V; Jacoby R; Banerjee-Basu S; Baxevanis AD; Lynch HT; Elliott RM; Collins FS Nat Genet; 2000 Jan; 24(1):27-35. PubMed ID: 10615123 [TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC). van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939 [TBL] [Abstract][Full Text] [Related]
9. Truncation of the C-terminus of human MLH1 blocks intracellular stabilization of PMS2 and disrupts DNA mismatch repair. Mohd AB; Palama B; Nelson SE; Tomer G; Nguyen M; Huo X; Buermeyer AB DNA Repair (Amst); 2006 Mar; 5(3):347-61. PubMed ID: 16338176 [TBL] [Abstract][Full Text] [Related]
10. Expression of the MutL homologue hMLH3 in human cells and its role in DNA mismatch repair. Cannavo E; Marra G; Sabates-Bellver J; Menigatti M; Lipkin SM; Fischer F; Cejka P; Jiricny J Cancer Res; 2005 Dec; 65(23):10759-66. PubMed ID: 16322221 [TBL] [Abstract][Full Text] [Related]
11. Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation. Nakagawa H; Lockman JC; Frankel WL; Hampel H; Steenblock K; Burgart LJ; Thibodeau SN; de la Chapelle A Cancer Res; 2004 Jul; 64(14):4721-7. PubMed ID: 15256438 [TBL] [Abstract][Full Text] [Related]
12. Nuclear import of human MLH1, PMS2, and MutLalpha: redundancy is the key. Leong V; Lorenowicz J; Kozij N; Guarné A Mol Carcinog; 2009 Aug; 48(8):742-50. PubMed ID: 19148896 [TBL] [Abstract][Full Text] [Related]
13. Defects of DNA mismatch repair in human prostate cancer. Chen Y; Wang J; Fraig MM; Metcalf J; Turner WR; Bissada NK; Watson DK; Schweinfest CW Cancer Res; 2001 May; 61(10):4112-21. PubMed ID: 11358834 [TBL] [Abstract][Full Text] [Related]
14. Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer. Nyström-Lahti M; Perrera C; Räschle M; Panyushkina-Seiler E; Marra G; Curci A; Quaresima B; Costanzo F; D'Urso M; Venuta S; Jiricny J Genes Chromosomes Cancer; 2002 Feb; 33(2):160-7. PubMed ID: 11793442 [TBL] [Abstract][Full Text] [Related]
15. Analysis of DNA mismatch repair gene expression and mutations in thyroid tumours. Ruschenburg I; Vollheim B; Stachura J; Cordon-Cardo C; Korabiowska M Anticancer Res; 2006; 26(3A):2107-12. PubMed ID: 16827152 [TBL] [Abstract][Full Text] [Related]
16. Multiple mutations are common at mouse Aprt in genotoxin-exposed mismatch repair deficient cells. Shin CY; Mellon I; Turker MS Oncogene; 2002 Mar; 21(11):1768-76. PubMed ID: 11896608 [TBL] [Abstract][Full Text] [Related]
17. Role for mismatch repair proteins Msh2, Mlh1, and Pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions. Schrader CE; Vardo J; Stavnezer J J Exp Med; 2002 Feb; 195(3):367-73. PubMed ID: 11828012 [TBL] [Abstract][Full Text] [Related]
18. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome). Hendriks YM; Jagmohan-Changur S; van der Klift HM; Morreau H; van Puijenbroek M; Tops C; van Os T; Wagner A; Ausems MG; Gomez E; Breuning MH; Bröcker-Vriends AH; Vasen HF; Wijnen JT Gastroenterology; 2006 Feb; 130(2):312-22. PubMed ID: 16472587 [TBL] [Abstract][Full Text] [Related]
19. Different mutator phenotypes in Mlh1- versus Pms2-deficient mice. Yao X; Buermeyer AB; Narayanan L; Tran D; Baker SM; Prolla TA; Glazer PM; Liskay RM; Arnheim N Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6850-5. PubMed ID: 10359802 [TBL] [Abstract][Full Text] [Related]
20. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer. Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]